Cannabis News
Market-moving headlines, earnings, and regulatory shifts across the cannabis sector
Track the developments that move cannabis stocks — from quarterly earnings and M&A deals to state-level legalization votes and federal policy changes. Articles are tagged with relevant stock tickers so you can see which companies are affected and jump straight to their market data.
DEA Cannabis Hearing Set for June 29 as Legal Challenges Mount
Federal marijuana rescheduling faces dual-track pressure through administrative hearings and federal court appeals, creating regulatory uncertainty.
Healthcare Research Drives Cannabis Sector Momentum in Early 2026
Healthcare research specialists reporting strong quarterly results signal growing institutional confidence in cannabis market fundamentals.
White House Urges Hemp Protection as November Deadline Looms
Biden administration calls on Congress to prevent hemp recriminalization amid industry uncertainty over regulatory framework changes.
White House Urges Congress to Block Hemp Recriminalization Deadline
Biden administration pushes lawmakers to prevent federal hemp restrictions from taking effect in November, signaling policy support for the $7 billion industry.
DEA Hearing on Cannabis Rescheduling Advances With Witness Schedule Set
Administrative law judge finalizes testimony lineup for landmark marijuana rescheduling proceedings beginning next week, marking critical juncture for federal policy.
DEA Schedules Cannabis Rescheduling Hearing, Only Opponents Invited
Federal hearing on marijuana rescheduling begins next week with testimony limited to reform opponents under DEA administrator directive.
DEA Rescheduling Hearing Approaches: Key Stakes for Cannabis Investors
Critical regulatory hearing could reshape federal cannabis policy and unlock institutional investment across the sector
Medical Tech Innovation Signals Broader Healthcare Investment Trends
AI diagnostics and oncology sectors show robust growth, highlighting investor appetite for disruptive healthcare technologies beyond traditional pharma plays.
Elite Athletes Drive Cannabis Research as Rescheduling Momentum Builds
Former Olympians pivot to cannabis research roles, highlighting shifting attitudes toward therapeutic use as federal rescheduling discussions accelerate industry legitimacy.
Michigan Medical Cannabis Revenue Plummets to $322K Amid Federal Chaos
Michigan's medical marijuana market collapses to historic lows as federal rescheduling uncertainty creates regulatory turmoil across state programs.
Delivra Health Brands Surges 10.5% on Light Volume Trading
DHBUF climbed to $0.14 amid modest trading activity, representing a significant single-day gain for the micro-cap CBD company.
CV Sciences Tumbles 12.4% as CBD Pioneer Faces Market Headwinds
CV Sciences drops to $0.04 amid elevated trading volume, highlighting ongoing challenges in the CBD sector.
Health Canada Addresses Cannabis Retail Oversight Gaps
Federal regulator responds to industry concerns about inconsistent retail cannabis supervision as provincial markets mature
GEEK THCX Hits 300+ California Dispensaries in Major Retail Push
Cannabis brand GEEK THCX expands to over 300 licensed California dispensaries, signaling strong retail adoption and consistent reorder velocity in the nation's largest cannabis market.
NY Cannabis Market Shows Stabilization as Women Drive Demand Growth
New York's cannabis market demonstrates signs of stabilization with women increasingly choosing marijuana over alcohol and cigarettes for wellness purposes.
WM Technology Plunges 11% as Cannabis Platform Struggles
MAPS stock fell to $0.39 on heavy volume, highlighting ongoing challenges for the cannabis technology platform amid market headwinds.
iAnthus Capital Holdings Drops 11.8% as Stock Trades at Zero
ITHUF shares fell 11.8% on elevated volume as the embattled MSO continues trading at effectively zero value amid ongoing restructuring challenges.
Missouri Fails to Clear Cannabis Records, Threatening Market Expansion
Hundreds of thousands of marijuana conviction records remain despite legalization deadline, creating regulatory hurdle for industry growth.
Cannabis Sin Tax Burden Threatens Industry Revenue Growth Potential
Excessive taxation on legal cannabis markets undermines legalization objectives while constraining sector profitability and competitive positioning.
Cannabis Sector Shows Early Signs of Momentum Shift
Positive market sentiment emerges across cannabis equities as institutional interest returns and regulatory optimism builds heading into 2024.